Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quell Therapeutics
Biotech
AstraZeneca pays $85M to Quell diabetes with 'one and done' drug
AstraZeneca is paying Quell Therapeutics $85 million upfront to collaborate on candidates including a “one and done” cure for Type 1 diabetes.
Nick Paul Taylor
Jun 9, 2023 2:00am
New CEO will lead Teva at top of new year—Chutes & Ladders
Dec 2, 2022 9:30am
Next-gen CAR player Quell Therapeutics drives into the fast lane
Nov 29, 2021 7:15am
